n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, Y; Kim, Y; Kwon, H; Park, J | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis.
Topics: Acetylglucosamine; Animals; Apoptosis; Cell Line; Diabetes Mellitus, Type 2; Glucosamine; Glycosylation; Insulin; Insulin Secretion; Insulin-Secreting Cells; Models, Biological; Oximes; Phenylcarbamates; Proteomics; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Streptozocin | 2007 |